Healthy volunteers test High-Dose flu drug for safety
NCT ID NCT06024421
First seen Feb 20, 2026 · Last updated Jun 16, 2026 · Updated 13 times
Summary
This study is testing high doses of the antiviral drug favipiravir in healthy volunteers to see if it is safe and how the body handles it. About 39 healthy adults will take either favipiravir or a placebo for 14 days. The goal is to understand side effects and drug levels in blood and sperm, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIOUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Bichat - Claude Bernard
RECRUITINGParis, 75018, France
Contact
Contact
Conditions
Explore the condition pages connected to this study.